Target intelligence / Profile preview

Cellular attachment co-receptor

Molecular classification
Receptor, Other
01

Overview

Cellular attachment co-receptors are a heterogeneous class of cell surface molecules, including both proteins and complex carbohydrates, that assist primary receptors in facilitating the attachment and entry of pathogens into host cells. These molecules, such as heparan sulfate proteoglycans, sialic acids, and specific chemokine receptors like CCR5 or CXCR4, often function by increasing the local density of viral or bacterial particles on the cell surface, thereby promoting interactions with high-affinity entry receptors. In many viral infections, including HIV-1 and SARS-CoV-2, the presence and density of these co-receptors are major determinants of viral tropism and infection efficiency. Therapeutic targeting of these molecules aims to prevent the initial stages of infection, using agents like small molecule antagonists (e.g., maraviroc) or polyanionic polymers (e.g., iota-carrageenan) that interfere with the binding interface. However, because these co-receptors often participate in vital physiological processes such as immune cell trafficking and cell-matrix interactions, drug development must address potential side effects related to the disruption of these normal biological functions.

Other names
Attachment factorViral co-receptorAccessory receptorEntry co-receptor
02

Mechanism of action

Drugs targeting cellular attachment co-receptors typically act by competitively binding to the viral attachment proteins or the co-receptors themselves, thereby preventing the initial adherence of the pathogen to the host cell surface and reducing the efficiency of viral entry.

03

Biological functions

Cell adhesionInfectionSignal transductionImmune response
04

Disease associations

InfectionInflammationCancer
05

Safety considerations

Off-target effects on physiological signaling (e.g., chemokine-mediated immune trafficking)Anticoagulant risks (for heparin-based inhibitors)Potential for viral resistance through alternative receptor usage
06

Interacting drugs

Maraviroc

6 more in the full profile.

07

Biomarkers

CCR5 tropismCXCR4 tropismCell surface expression of specific co-receptors (e.g., CD147, NRP1)

Beyond the preview

Go deeper on Cellular attachment co-receptor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular attachment co-receptor.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call